Cargando…
Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study
To report clinical presentations and factors affecting outcomes in rhino-orbital-cerebral mucormycosis following COVID-19. METHODS: Retrospective multi-centric interventional case series of 58 eyes with rhino-orbital-cerebral mucormycosis. Demography, clinical parameters and management outcomes were...
Autores principales: | Dave, Tarjani Vivek, Gopinathan Nair, Akshay, Hegde, Raghuraj, Vithalani, Nidhi, Desai, Savari, Adulkar, Namrata, Kamal, Saurabh, Mittal, Raman, Bradoo, Renuka A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425514/ https://www.ncbi.nlm.nih.gov/pubmed/34314399 http://dx.doi.org/10.1097/IOP.0000000000002030 |
Ejemplares similares
-
Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis
por: Sreshta, Kanduri, et al.
Publicado: (2021) -
Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients
por: Sharma, Vagisha, et al.
Publicado: (2023) -
Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B
por: Safi, Mustafa, et al.
Publicado: (2020) -
Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study
por: Gandhi, Aastha, et al.
Publicado: (2022) -
Optimization of Oral Posaconazole Step Down Therapy in Management of Rhino-Orbital-Cerebral Mucormycosis (ROCM): Outcome of an Institutional Protocol
por: Mukherjee, Monoj, et al.
Publicado: (2023)